Antiretroviral Drugs
key details
| Value | £24,899,339 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | Wales |
| Deadline | 15 Nov 2024 |
| Procedure | open |
| OCID | ocds-h6vhtk-04ac3a |
Awards (10)
This procurement was awarded to 10 suppliers. Values shown are per-award; the notice total is £24,899,339.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Amarox Pharma shared | · | · | active |
| Aurobindo (Milpharm Ltd) shared | · | · | active |
| Gilead Sciences Limited shared | · | · | active |
| Glenmark Pharmaceuticals shared | · | · | active |
| Janssen Limited shared | · | · | active |
| Lupin Healthcare (UK) Limited shared | · | · | active |
| Merck Sharp & Dohme (UK) Limited shared | · | · | active |
| Sun Pharma UK Ltd shared | · | · | active |
| Viatris UK Healthcare Limited shared | · | · | active |
| ViiV Healthcare shared | · | · | active |
description
Antiretroviral Drugs
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 15 Oct 2024 | Contract notice (F02) | Earlier regulations | 033163-2024 |
| 6 May 2025 | Contract award notice (F03) | Earlier regulations | 019124-2025 |
more from Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
- Parenteral Nutrition · £1,054,094 · 29 May 2025
- Aseptics Medicines (Including Cytotoxics) · £7,600,474 · 22 Nov 2024
- Contrast Media · £12,329,124 · 28 Sept 2023
- Erythropoietin Stimulating Agents & IV Iron · £15,282,400 · 1 Sept 2023
- Sevoflurane and Vaporisers · £2,914,560 · 15 Aug 2023
- Clozapine Tablets and Blood Testing Service · £2,303,750 · 4 Apr 2023
- Supply of Methoxyflurane (Penthrox) to Welsh Ambulance Service Trust · 9 Feb 2023
- Disinfectants · 12 Jan 2021
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.